AnalytiXIN creates new Indiana healthcare-based consortium to advance data-driven clinical research and improve health outcomes
New shared platform will use consented health data to facilitate life sciences research, advance healthcare, and to engage patients via precision medicine INDIANAPOLIS – AnalytiXIN today announced the launch of a new consortium to help healthcare organizations across Indiana better identify and access comprehensive, consented clinical and genomic health data. It is a continued investment to improve patient outcomes and drive efficiencies to accelerate clinical research. Access to these diverse datasets will allow researchers to quickly develop and conduct more accurate and personalized studies, enabling more effective healthcare interventions, further establishing Indiana as a leader in health sciences data analytics. Several leading Indiana-based healthcare companies, including Eli Lilly and Company (“Lilly”), Indiana University (IU) Health, IU School of Medicine, and the Indiana Health Information Exchange (IHIE) have pledged unprecedented commitment to this collaboration. “We’re excited to work with our [...]
